quinazolines has been researched along with leukotriene b4 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaraz, MJ; Gonzalez-Tejero, A; Molina, P; Rioja, I; Tárraga, A; Terencio, MC; Ubeda, A | 1 |
| Dannhardt, G; Danz, H; Hamburger, M; Simon, HU; Stoyanova, S; Thomet, OA; Ulbrich, H | 1 |
| Chen, Z; Rola-Pleszczynski, M; Stankova, J | 1 |
| Diacovo, TG; Puri, KD; Randis, TM; Zhou, H | 1 |
| Andoh, T; Kuraishi, Y | 1 |
5 other study(ies) available for quinazolines and leukotriene b4
| Article | Year |
|---|---|
Inhibition of leukocyte functions by the alkaloid isaindigotone from Isatis indigotica and some new synthetic derivatives.
Topics: Alkaloids; Animals; Brassicaceae; Cells, Cultured; Chromatography, Thin Layer; Dinoprostone; Free Radical Scavengers; Humans; Inflammation; Inflammation Mediators; Inhibitory Concentration 50; Leukocytes; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Macrophages; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Neutrophils; Nitric Oxide Synthase; Plants, Medicinal; Quinazolines; Structure-Activity Relationship; Xanthine Oxidase | 2001 |
Inhibitory activity of tryptanthrin on prostaglandin and leukotriene synthesis.
Topics: Animals; Brassicaceae; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoenzymes; Leukotriene B4; Membrane Proteins; Neutrophils; Phytotherapy; Plant Extracts; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Quinazolines; Sheep | 2002 |
Activation of ERK1/2 by platelet-activating factor receptor is independent of receptor internalisation and G-protein activation.
Topics: Animals; Arrestins; beta-Adrenergic Receptor Kinases; Blotting, Western; Cell Line; Chlorocebus aethiops; Clathrin-Coated Vesicles; Cloning, Molecular; COS Cells; Cyclic AMP-Dependent Protein Kinases; Dynamins; Endocytosis; ErbB Receptors; Humans; Isoproterenol; Leukotriene B4; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; Pertussis Toxin; Phosphorylation; Platelet Membrane Glycoproteins; Quinazolines; Receptors, G-Protein-Coupled; Signal Transduction; Sucrose; Transfection; Tyrphostins | 2003 |
Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils.
Topics: Adenine; Animals; Arthritis, Experimental; Chemotaxis, Leukocyte; Class I Phosphatidylinositol 3-Kinases; Class Ib Phosphatidylinositol 3-Kinase; Edema; Enzyme Inhibitors; Hindlimb; Isoenzymes; Leukotriene B4; Mice; Mice, Inbred NOD; Mice, Inbred Strains; Mice, Knockout; Mice, Transgenic; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Infiltration; Neutrophils; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinazolines | 2008 |
Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Administration, Topical; Animals; Antipruritics; Cells, Cultured; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Injections, Intradermal; Keratinocytes; Leukotriene B4; Male; Mice; Mice, Inbred ICR; Oligopeptides; Phosphodiesterase 4 Inhibitors; Phthalic Acids; Pruritus; Quinazolines; Receptor, PAR-2; Skin; Tryptases | 2014 |